Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 263

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

VSIG‐3 as a ligand of VISTA inhibits human T‐cell function

Open access
Wang, Jinghua, Wu, Guoping, Manick, Brian, Hernandez, Vida, Renelt, Mark, Erickson, Christian, Guan, Joanna, Singh, Ravinder, Rollins, Simone, Solorz, Alicia, Bi, Ming, Li, Jun, Grabowski, David, Dirkx, Janette, Tracy, Camrin, Stuart, Thomas, Ellinghuysen, Chad, Desmond, Daniel, Foster, Craig, Kalabokis, Vassilios·2019·Immunology

Abstract

Summary: B7 family members and their receptors play a central role in the regulation of T‐cell responses through T‐cell co‐stimulation and co‐inhibition pathways that constitute attractive targets for the development of immunotherapeutic drugs. In this study, we report that VSIG‐3/IGSF 11 is a ligand of B7 family member VISTA/PD‐1H and inhibits human T‐cell functions through a novel VSIG‐3/VISTA pathway. An extensive functional ELISA binding screening assay reveals that VSIG‐3 binds to the new B7 family member VISTA but does not interact with other known members of the B7 family. Under the same experimental conditions, we did not observe any significant interaction between VSIG‐8 and VISTA. In addition, VSIG‐3 inhibits human T‐cell proliferation in the presence of T‐cell receptor signaling. Furthermore, VSIG‐3 significantly reduces cytokine and chemokine production by human T cells including IFN‐γ, IL‐2, IL‐17, CCL 5/Rantes, CCL 3/MIP‐1 α, and CXCL 11/I‐TAC. Anti‐VISTA neutralization antibodies attenuate the binding of VSIG‐3 and VISTA, as well as VSIG‐3‐induced T‐cell inhibition. Hence, we have identified a novel ligand for VISTA that is able to inhibit human T‐cell proliferation and cytokine production. This unique VSIG‐3/VISTA co‐inhibitory pathway may provide new strategies for the treatment of human cancers, autoimmune disorders, infection, and transplant rejection and may aid in the design of better vaccines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/imm.13001

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 263

Metadata

Authors
Wang, J., Wu, G., Manick, B., Hernandez, V., Renelt, M., Erickson, C., Guan, J., Singh, R., Rollins, S., Solorz, A., Bi, M., Li, J., Grabowski, D., Dirkx, J., Tracy, C., Stuart, T., Ellinghuysen, C., Desmond, D., Foster, C., & Kalabokis, V.
Venue
Immunology
Publisher
Wiley
Published
2018-10-10
Volume
156
Issue
1
Pages
74-85
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2890463012
Cited by
263
References
16
FWCI
7.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VSIG‐3 as a ligand of VISTA inhibits human T‐cell function. https://app.cochat.ai/papers/10.1111/imm.13001
The paper
Wang, J., Wu, G., Manick, B., Hernandez, V., Renelt, M., Erickson, C., Guan, J., Singh, R., Rollins, S., Solorz, A., Bi, M., Li, J., Grabowski, D., Dirkx, J., Tracy, C., Stuart, T., Ellinghuysen, C., Desmond, D., Foster, C., & Kalabokis, V. (2019). VSIG‐3 as a ligand of VISTA inhibits human T‐cell function. Immunology. https://doi.org/10.1111/imm.13001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.